Evidence map›Paper›PMID 34579484›Full record

ArticlePlants (Basel, Switzerland)2021

Morphology, Anatomy and Secondary Metabolites Investigations of

Fadia S Youssef, Elisa Ovidi, Nawal M Al Musayeib, Mohamed L Ashour

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Anticancer Potential of Bioactive Compounds inCancer management and research · 2025
    Review
  3. Chemometric discrimination of eightCurrent research in food science · 2024
    Article
  4. Characterization ofACS omega · 2023
    Article
  5. Article
  6. Article
  7. Silviridoside: A New Triterpene Glycoside fromMolecules (Basel, Switzerland) · 2022
    Article
  8. Prophylactic Anti-Osteoporotic Effect ofAntioxidants (Basel, Switzerland) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Metabolomics-Based Profiling ofAntioxidants (Basel, Switzerland) · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Fadia S YoussefDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbasia, Cairo 11566, Egypt.ORCID 0000-0002-5871-2639
Elisa OvidiDepartment for the Innovation in Biological, Agrofood and Forestal Systems, Tuscia University, 01100 Viterbo, Italy.ORCID 0000-0001-8876-6331
Nawal M Al MusayeibDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.
Mohamed L AshourDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Abbasia, Cairo 11566, Egypt.ORCID 0000-0002-9270-6267
Ain Shams University · EGKing Saud University · SAUniversità degli Studi della Tuscia · IT

Funding

King Saud University Researchers Supporting Project number (RSP-2021/294), King Saud University, Riyadh, Saudi Arabia. RSP-2021/294
6 · The paper itself

Abstract

In-depth botanical characterization was performed on

Indexed as

anatomyanti-tuberculous activityLamiaceae morphologymolecular dockingPremna odoratasecondary metabolites

Identifiers

PMID34579484
PMCPMC8467642
OpenAlexW3204759150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.